Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

Wilcox, MH orcid.org/0000-0002-4565-2868, Gerding, DN, Poxton, IR et al. (18 more authors) (2017) Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. New England Journal of Medicine, 376 (4). pp. 305-317. ISSN 0028-4793

Abstract

Metadata

Authors/Creators:
  • Wilcox, MH ORCID logo https://orcid.org/0000-0002-4565-2868
  • Gerding, DN
  • Poxton, IR
  • Kelly, C
  • Nathan, R
  • Birch, T
  • Cornely, OA
  • Rahav, G
  • Bouza, E
  • Lee, C
  • Jenkin, G
  • Jensen, W
  • Kim, Y-S
  • Yoshida, J
  • Gabryelski, L
  • Pedley, A
  • Eves, K
  • Tipping, R
  • Guris, D
  • Kartsonis, N
  • Dorr, M-B
Copyright, Publisher and Additional Information: © 2017 Massachusetts Medical Society. Reproduced in accordance with the publisher's self-archiving policy.
Keywords: Clostridium difficile, recurrence, monoclonal antibodies, bezlotoxumab
Dates:
  • Published: 26 January 2017
  • Accepted: 16 November 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Dec 2016 14:54
Last Modified: 09 Nov 2017 14:27
Published Version: https://doi.org/10.1056/NEJMoa1602615
Status: Published
Publisher: Massachusetts Medical Society
Identification Number: https://doi.org/10.1056/NEJMoa1602615

Share / Export

Statistics